{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:12:35Z","timestamp":1777291955117,"version":"3.51.4"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Worldwide, demographic ageing is a major social, economic and health challenge. Despite the increase in life expectancy, elderly often live with multiple chronic conditions, exposing them to multiple medications. Concerns have been raised about the growing issue of inappropriate long-term usage of proton-pump inhibitors (PPI), which have been associated with adverse outcomes and increased healthcare costs. Deprescribing is a recommended intervention to reduce or withdraw medicines that might be causing harm or might no longer be of benefit. This protocol details a trial to assess the effectiveness and cost-effectiveness of a collaborative deprescribing intervention of PPI among community-dwelling elderly, involving community pharmacists and general practitioners.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and analysis<\/jats:title>\n<jats:p>A pragmatic, multicentre, two-arm, non-randomised controlled trial of a structured PPI collaborative deprescribing intervention in the primary care setting with a 6-month follow-up will be conducted. Patients must be 65 years old or older, live in the community and have been using PPI for more than 8 weeks. We hypothesize that the intervention will reduce the PPI usage in the intervention group compared to the control group. The primary outcome is the successful discontinuation or dose decrease of any PPI, defined as a statistically significant absolute 20% reduction in medication use between the intervention and control groups at 3- and 6-month follow-ups. An economic evaluation will be conducted alongside the trial. This study was approved by the Ethics Research Committee of Nova Medical School, NOVA University of Lisbon and by the Ethics Committee from the Local Health Unit Alto Minho, Portugal.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>This pragmatic trial will provide evidence on the effectiveness and cost-effectiveness of a patient-centred collaborative deprescribing intervention in the community setting in Portugal. It will also inform improvements for the development of future multi-faceted interventions that aim to optimise medication for the community-dwelling elderly.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Clinical trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN49637686\" xlink:type=\"simple\">ISRCTN 49637686<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0298181","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:29:24Z","timestamp":1711474164000},"page":"e0298181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and cost-effectiveness of a collaborative deprescribing intervention of proton-pump-inhibitors on community-dwelling older adults: Protocol for the C-SENIoR, a pragmatic non-randomized controlled trial"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-0996","authenticated-orcid":true,"given":"S\u00f3nia","family":"Romano","sequence":"first","affiliation":[]},{"given":"Luis","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Pedro","family":"Guerreiro","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Braga","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Teixeira Rodrigues","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1870-1430","authenticated-orcid":true,"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Perelman","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"pone.0298181.ref001","article-title":"The 2018 Ageing Report.","author":"European Commission","year":"2017","journal-title":"Underlying Assumptions & Projection Methodologies."},{"key":"pone.0298181.ref002","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0140-6736(15)00516-4","article-title":"The World report on ageing and health: a policy framework for healthy ageing","volume":"387","author":"J Beard","year":"2016","journal-title":"Lancet"},{"key":"pone.0298181.ref003","doi-asserted-by":"crossref","first-page":"2235042X1987093","DOI":"10.1177\/2235042X19870934","article-title":"Prevalence of multimorbidity in community settings: A systematic review and meta-analysis of observational studies.","volume":"9","author":"H Nguyen","year":"2019","journal-title":"J Comorb"},{"key":"pone.0298181.ref004","author":"OECD\/European Union","year":"2020","journal-title":"Health at a Glance: Europe 2020: State of Health in the EU Cycle"},{"key":"pone.0298181.ref005","doi-asserted-by":"crossref","first-page":"e43617","DOI":"10.1371\/journal.pone.0043617","article-title":"Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic Review","volume":"7","author":"D Opondo","year":"2012","journal-title":"PLoS One"},{"key":"pone.0298181.ref006","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00228-015-1954-4","article-title":"Potentially inappropriate prescribing in community-dwelling older people across Europe: A systematic literature review","volume":"71","author":"E Tommelein","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0298181.ref007","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review.","volume":"62","author":"TR Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"pone.0298181.ref008","article-title":"Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15\u2005years in Ireland: a repeated cross-sectional study","volume":"5","author":"F Moriarty","journal-title":"BMJ Open"},{"key":"pone.0298181.ref009","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A systematic review of hospitalization resulting from medicine-related problems in adult patients","volume":"78","author":"A al Hamid","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0298181.ref010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1060028013504904","article-title":"Association Between Potentially Inappropriate Medications From the Beers Criteria and the Risk of Unplanned Hospitalization in Elderly Patients","volume":"48","author":"SD Price","year":"2014","journal-title":"Annals of Pharmacotherapy"},{"key":"pone.0298181.ref011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/glw140","article-title":"Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: A prospective cohort study","volume":"72","author":"E Wallace","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"pone.0298181.ref012","author":"World Health Organization","year":"2017","journal-title":"Medication without harm\u2014Global patient safety challenge on medication safety"},{"key":"pone.0298181.ref013","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: The process of deprescribing","volume":"175","author":"IA Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"pone.0298181.ref014","unstructured":"Medication Safety in Polypharmacy. Geneva: World Health Organization; (WHO\/UHC\/S."},{"key":"pone.0298181.ref015","doi-asserted-by":"crossref","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice","author":"E Reeve","DOI":"10.1111\/bcp.12732"},{"key":"pone.0298181.ref016","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis","volume":"35","author":"HE Bloomfield","year":"2020","journal-title":"J Gen Intern Med"},{"key":"pone.0298181.ref017","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.sapharm.2016.08.006","article-title":"Community-dwelling older people\u2019s attitudes towards deprescribing in Canada.","volume":"13","author":"C Sirois","year":"2017","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"pone.0298181.ref018","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijge.2018.05.006","article-title":"Polypharmacy and Willingness to Deprescribe Among Elderly with Chronic Diseases.","volume":"12","author":"L Jia Hao","year":"2018","journal-title":"Int J Gerontol"},{"key":"pone.0298181.ref019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cger.2017.01.004","article-title":"The Role of Patient Preferences in Deprescribing.","volume":"33","author":"HM Holmes","year":"2017","journal-title":"Clin Geriatr Med"},{"key":"pone.0298181.ref020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: A systematic review.","volume":"30","author":"E Reeve","year":"2013","journal-title":"Drugs Aging"},{"key":"pone.0298181.ref021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12875-019-0953-4","article-title":"Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland.","volume":"20","author":"S Zechmann","year":"2019","journal-title":"BMC Fam Pract"},{"key":"pone.0298181.ref022","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults The D-PRESCRIBE Randomized Clinical Trial","volume":"320","author":"P Martin","year":"2018","journal-title":"JAMA"},{"key":"pone.0298181.ref023","first-page":"1","article-title":"American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults","volume":"00","author":"Panel Expert By the American Geriatrics Society 2015 Beers Criteria Update","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"pone.0298181.ref024","doi-asserted-by":"crossref","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries.","author":"A Renom-Guiteras","DOI":"10.1007\/s00228-015-1860-9"},{"key":"pone.0298181.ref025","article-title":"Operacionaliza\u00e7\u00e3o para Portugal da Lista EU(7)-PIM para Identifica\u00e7\u00e3o de Medicamentos Potencialmente Inapropriados nos Idosos","volume":"33","author":"DA Rodrigues","journal-title":"Acta Med Port"},{"key":"pone.0298181.ref026","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"D O\u2019mahony","year":"2015","journal-title":"Age Ageing"},{"key":"pone.0298181.ref027","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/PPA.S219346","article-title":"Prevalence of potentially inappropriate medication in the older adult population within primary care in Portugal: A nationwide cross-sectional study.","volume":"13","author":"PA Sim\u00f5es","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"pone.0298181.ref028","unstructured":"Statistics Portugal\u2014Web Portal, https:\/\/www.ine.pt\/xportal\/xmain?xpgid=ine_main&xpid=INE&xlang=en (accessed 8 August 2022)."},{"key":"pone.0298181.ref029","unstructured":"ATC-DDD Toolkit, https:\/\/www.who.int\/tools\/atc-ddd-toolkit (accessed 3 December 2022)."},{"key":"pone.0298181.ref030","unstructured":"National Health Service\u2014Identity card for primary health care, https:\/\/bicsp.min-saude.pt\/pt\/biufs\/Paginas\/default.aspx (accessed 8 August 2022)."},{"key":"pone.0298181.ref031","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: Defining standard protocol items for clinical trials","volume":"158","author":"AW Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"pone.0298181.ref032","doi-asserted-by":"crossref","first-page":"e0122246","DOI":"10.1371\/journal.pone.0122246","article-title":"What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process.","volume":"10","author":"B Farrell","year":"2015","journal-title":"PLoS One"},{"key":"pone.0298181.ref033","first-page":"1","volume-title":"Supress\u00e3o \u00c1cida: Utiliza\u00e7\u00e3o dos Inibidores da Bomba de Prot\u00f5es e das suas Alternativas Terap\u00eauticas","author":"Norma da Dire\u00e7\u00e3o Geral de Sa\u00fade n\u00b0 036\/2011.","year":"2011"},{"key":"pone.0298181.ref034","first-page":"3","volume-title":"Inibidores da bomba de prot\u00f5es (IBP). Recomenda\u00e7\u00f5es Terap\u00eauticas","author":"INFARMED","year":"2017"},{"key":"pone.0298181.ref035","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/bcp.13912","article-title":"Availability and readability of patient education materials for deprescribing: An environmental scan","volume":"85","author":"MA Fajardo","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0298181.ref036","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis","author":"AT Page","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0298181.ref037","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1001\/archinte.1997.00440400055007","article-title":"Adverse Events After Discontinuing Medications in Elderly Outpatients","volume":"157","author":"T. Graves","year":"1997","journal-title":"Arch Intern Med"},{"key":"pone.0298181.ref038","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0974-7788.76794","article-title":"Understanding survival analysis: Kaplan-Meier estimate.","volume":"1","author":"MK Goel","year":"2010","journal-title":"Int J Ayurveda Res"},{"key":"pone.0298181.ref039","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1590\/S1516-31802013000100018","article-title":"Cross-cultural adaptation of the Beliefs about Medicines Questionnaire into Portuguese","volume":"131","author":"T Salgado","year":"2013","journal-title":"Sao Paulo Medical Journal"},{"key":"pone.0298181.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"N Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"pone.0298181.ref041","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life.","volume":"16","author":"EuroQol Group","year":"1990","journal-title":"Health Policy (New York)"},{"key":"pone.0298181.ref042","article-title":"A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set","author":"PL Ferreira","journal-title":"Quality of Life Research"},{"key":"pone.0298181.ref043","first-page":"81","article-title":"Contributo para a valida\u00e7\u00e3o concorrente de uma medida de ades\u00e3o aos tratamentos.","volume":"2","author":"AB Delgado","year":"2001","journal-title":"Psicologia, Sa\u00fade & Doen\u00e7as"},{"key":"pone.0298181.ref044","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1370\/afm.1838","article-title":"Effectiveness of a Multifaceted Intervention for Potentially Inappropriate Prescribing in Older Patients in Primary Care: A Cluster-Randomized Controlled Trial (OPTI-SCRIPT Study).","volume":"13","author":"B Clyne","year":"2015","journal-title":"Ann Fam Med"},{"key":"pone.0298181.ref045","article-title":"Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.","volume":"185","author":"AT Rodrigues","journal-title":"Respir Med"},{"key":"pone.0298181.ref046","article-title":"Orienta\u00e7\u00f5es metodol\u00f3gicas para estudos de avalia\u00e7\u00e3o econ\u00f3mica de tecnologias de sa\u00fade.","author":"J Perelman","journal-title":"Lisboa"},{"issue":"2","key":"pone.0298181.ref047","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11136-013-0448-z","article-title":"The valuation of the EQ-5D in Portugal.","volume":"23","author":"LN Ferreira","year":"2014","journal-title":"Quality of Life Research"},{"key":"pone.0298181.ref048","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programme","author":"M Drummond","year":"2005","edition":"3"},{"key":"pone.0298181.ref049","unstructured":"Portugal. Boletim do Trabalho e Emprego No. 24, 29\/06\/2018. Contrato Coletivo de Trabalho\u2014Altera\u00e7\u00e3o n.\u00b0 183\/2018, de 29 de junho (in Portuguese)., https:\/\/files.diariodarepublica.pt\/bases_especiais\/regtrab\/2018\/06\/29\/115669132.pdf (accessed 5 June 2023)."},{"key":"pone.0298181.ref050","unstructured":"Portugal. Ministry of Health. Ordinance No. 254\/2018 (September 7 2018). Altera a Portaria n.o 207\/2017, de 11 de julho, que aprova os Regulamentos e as Tabelas de Pre\u00e7os das Institui\u00e7\u00f5es e Servi\u00e7os Integrados no Servi\u00e7o Nacional de Sa\u00fade (SNS), procede \u00e0 regulamenta\u00e7\u00e3o do Sistema Integrado de Gest\u00e3o de Inscritos para Cirurgia (SIGIC) (in Portuguese). Republic Diary No. 173\/2018."},{"key":"pone.0298181.ref051","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: The role of cost-effectiveness acceptability curves.","volume":"10","author":"E Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"pone.0298181.ref052","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jval.2016.02.020","article-title":"On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?","volume":"19","author":"L Vallejo-Torres","year":"2016","journal-title":"Value in Health"},{"key":"pone.0298181.ref053","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.","volume":"25","author":"D Husereau","year":"2022","journal-title":"Value in Health"},{"key":"pone.0298181.ref054","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1111\/jgs.16875","article-title":"Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review.","volume":"68","author":"ND Forsat","year":"2020","journal-title":"J Am Geriatr Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:29:51Z","timestamp":1711474191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298181"}},"subtitle":[],"editor":[{"given":"Mohammad Jamil","family":"Rababa","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0298181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}